Clinical trial
Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
NCT00142051 · Boston Children's Hospital, Other · Terminated
Key facts
| NCT number | NCT00142051 |
|---|---|
| Title | Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis |
| Official title | Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis |
| Lead sponsor | Boston Children's Hospital, Other |
| Collaborators | FDA Office of Orphan Products Development U.S. Fed |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease |
| Intervention type | Drug |
| Interventions | nitric oxide, oxygen |
| Enrollment | 18 |
| Start date | Apr 1, 2005 |
| Primary completion | Aug 1, 2013 |
| Completion | Aug 1, 2013 |
| First posted | Sep 2, 2005 |
| Last update posted | Feb 23, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: